Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Jahreis GP et al. | 1998 | intact cell/cell culture, CEM-CM3 (human acute lymphoblastic leukemia) cells | magnetic field, 50/60 Hz | 0.1 mT |
Miyakoshi J et al. | 1996 | intact cell/cell culture, CHO (Chinese hamster ovary) cells | magnetic field, 50/60 Hz | 5 mT |
Miyakoshi J et al. | 1998 | intact cell/cell culture, CHO-K1 (Chinese hamster ovary K1) cells | magnetic field, 50/60 Hz, co-exposure | 5–400 mT |
Czyz J et al. | 2004 | intact cell/cell culture, D3 (murine embryonic stem cell line, p53-deficient and wild type) | magnetic field, 50/60 Hz, power transmission line | 100 µT–2.3 mT |
Kristupaitis D et al. | 1998 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) (wild-type, LYN-deficient, SYK-deficient, PLC-gamma2-deficient clones) | magnetic field, 50/60 Hz, co-exposure | 0.1 mT |
Dibirdik I et al. | 1998 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) (wild-type, LYN-deficient, SYK-deficient, PLC-gamma2-deficient clones) | magnetic field, 50/60 Hz | 100 µT |
Morehouse CA et al. | 2000 | intact cell/cell culture, Daudi (Burkitt's lymphoma cell line) cells | magnetic field, 50/60 Hz | 12.5–500 µT |
Wu RY et al. | 2000 | intact cell/cell culture, Daudi (Burkitt's lymphoma cell line) cells | magnetic field, 50/60 Hz | 800 µT |
Bouwens M et al. | 2012 | intact cell/cell culture, Detroit 562 cells (human pharyngeal cells), THP-1 cells (human monocytic leukemia cell line) and human monocytes | magnetic field, low frequency, 50/60 Hz | 5 µT |
Volpe P et al. | 2005 | intact cell/cell culture, FL cells (Friend erythroleukemia cells) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.